# Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients

> **NCT01620125** · EARLY_PHASE1 · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 12 (actual)

## Conditions studied

- Type 2 Diabetes
- Insulin Resistance

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus reuteri DSM 17938

## Key facts

- **NCT ID:** NCT01620125
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01620125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01620125, "Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01620125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*